Segall Bryant & Hamill’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.19M Sell
75,867
-6,331
-8% -$141K 0.03% 444
2026
Q1
$1.4M Buy
82,198
+33,380
+68% +$716K 0.02% 458
2025
Q4
$1.25M Buy
+48,818
New +$1.12M 0.02% 483
2021
Q2
Sell
-30,075
Closed -$1.34M 814
2021
Q1
$1.34M Buy
30,075
+14,000
+87% +$654K 0.01% 519
2020
Q4
$681K Buy
16,075
+5,250
+48% +$171K 0.01% 520
2020
Q3
$319K Buy
+10,825
New +$298K ﹤0.01% 620

Other funds holding PGNY

Segall Bryant & Hamill's PGNY Position: Q2 2026 in Review

Segall Bryant & Hamill reduced its Progyny (PGNY) stake by 7.7% in Q2 2026, selling an estimated $141K and leaving 75,867 shares worth $2.19M. The position accounts for 0.03% of the portfolio, ranked #444.

Segall Bryant & Hamill first reported a position in PGNY in Q3 2020 and has held it in 6 quarters since. 312 funds tracked by Wall St. Rank hold PGNY as of Q2 2026.

  • Segall Bryant & Hamill held 75,867 shares of Progyny worth $2.19M as of Q2 2026.
  • Segall Bryant & Hamill sold 6,331 Progyny shares in Q2 2026, an estimated $141K.
  • Progyny made up 0.03% of Segall Bryant & Hamill's portfolio in Q2 2026, its #444 holding.
  • Segall Bryant & Hamill first reported a position in Progyny in Q3 2020 and has held it in 6 quarters since.
  • 312 funds tracked by Wall St. Rank held Progyny as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.